OMDAOmada Health, Inc.
Is the business good?
6 of 9 health tests passed. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is OMDA?
Omada Health, Inc. earns −1.2% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
Return on invested capital · cost of capital 9.0% · 10 points below what the capital costs: growth destroys value
- Operating margin
- −0.15%
Operating margin · Health Information Services median 2.8% · 12 months to Q2 2026
- Share count, year on year
- +191%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 16%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2023 | −54% |
| FY2024 | −26% |
| FY2025 | −4.6% |
Details›
- Gross margin12 months to Q2 2026
- 68%
- Operating margin12 months to Q2 2026
- −0.15%
- Net margin12 months to Q2 2026
- 1.4%
- Free cash flow margin
- 7.3%
- R&D as % of revenue
- 16%
- Revenue, trailing twelve months
- $310M
- Free cash flow, trailing twelve months
- $23M
- Net income, trailing twelve months
- $4.3M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −1.2%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Health Information Services
The closest names by size in the same industry